<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2022</study_start_year><data_sharing_plan>IPD Sharing (as of September 2023): Undecided
Description: undecided</data_sharing_plan><condition>Colorectal Adenoma</condition><condition>Colorectal Cancer</condition><condition>Colorectal Neoplasms</condition><condition>Adenoma</condition><disease>Colorectal Adenoma</disease><disease>Colorectal Cancer</disease><disease>Colorectal Neoplasms</disease><disease>Adenoma</disease><study_type>Observational</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2745777</full_dataset_link><location>China</location><study_start_month>10</study_start_month><keyword>Diagnostic test</keyword><keyword>CtDNA</keyword><keyword>Methylation</keyword><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>A Study on a Blood-based Dual-target Test for CRC Detection</name><description>To evaluate the effectiveness and accuracy of the ctDNA dual-target test kit in a large case-control cohort for the detection of colorectal cancer and advanced adenomas.</description><dates><creation>2022-10-15</creation></dates><accession>2745777</accession><cross_references><ClinicalTrials___gov>NCT05508503</ClinicalTrials___gov></cross_references></HashMap>